Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Event
DIA 2023 Global Annual Meeting
June 25 - June 29, 2023
Boston, MA
The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, DIA 2023 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.
We look forward to welcoming you on our new booth #800. We’re also delighted to provide information on when you can hear firsthand from our experts!
Virtual Short Courses
Wednesday, June 14th from 9:30 am – 12:30 pm
Introduction to Cell and Gene Therapies: Specific Regulatory, CMC, Non-clinical and Clinical Requirements and Considerations
- Dr. Luman Wing, Vice President, Technical
- Christiane Niederlaender, Vice President, Technical
- Steven Winitsky, Vice President, Technical
Signal Management in Pharmacovigilance
- Kausik Maiti, Senior Medical Director
- Himanshu Bhatnagar, Associate Medical Director
- Vineeta Malik, Director, Safety Medical Writing
Monday, June 26th
Thomas Pietsch
Global Head of Scientific Data Technology and AI
Monday, June 26th from 2:35 pm - 3:05 pm
Speaker | Scaling Large Language Models in Clinical Research for Unprecedented Efficiencies
Kristina Reeder
Director, Patient Engagement
Monday, June 26th from 2:50 pm – 3:10 pm
Speaker | "Early planning for clinical trial diversity: How upfront strategies avoid additional time and cost"
The FDA's Draft Guidance for Race and Ethnicity Diversity Plans and the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act requires clinical trial sponsors to develop diversity plans that ensure broader representation of a disease population. This session discusses upfront patient-focused strategies that save your development program valuable time and extra costs when implemented early while providing regulatory rigor and feasible execution.
Tuesday, June 27th
Alex Gee
Senior Director, Market Access
Tuesday, June 27th from 1:15 pm – 2:15 pm
Speaker | Implications of the 2022 US Inflation Reduction Act on Biosimilars
Jan Horsky
Scientific Data Strategy Director
Tuesday, June 27th from 1:15 pm – 2:15 pm
Chair | Quality in the real-world: Identifying and addressing inaccuracies and gaps in routinely collected patient data
Thursday, June 29th
Jaime Smith
Senior Director, Global Head Scientific Data
Thursday, June 29th from 8:30 am – 9:30 am
Speaker | Reverse-Engineering Digital Endpoints to Improve Trial Design and Expand Diversity and Access
Thursday, June 29th from 9:45 am – 10:45 am
Panelist | Process Automation and Artificial Intelligence in the Field: Practical Applications